Merck & Co said on Tuesday it was planning to produce and donate investigational Sudan Ebola virus vaccine to a global non-profit organization’s research program in Uganda, which is facing an outbreak of the disease. The investigational vaccine that will be donated to IAVI is similar to Merck’s Ervebo vaccine, …
Read More »